Skip to main content

PREDICIENDO GENOTIPOS EXITOSOS DE MYCOBACTERIUM TUBERCULOSIS COMBINANDO GENOMICA DE POBLACIONES, APROXIMACIONES FUNCIONALES Y MODELOS DE INFECCION

PID2019-104477RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Tesis doctoral (DoctoralThesis)

Culture-Free Sequencing of Mycobacterium Tuberculosis for Diagnosis and Genetic Diversity Identification

  • Mariner Llicer, Carla
[ES] La detección y diagnóstico de resistencias en Mycobacterium tuberculosis (MTB) supone un reto para el control de la tuberculosis (TB). La técnica diagnóstica implica el cultivo de muestras diagnósticas, pero este proceso es lento y retrasa los resultados hasta meses demorando la prescripción del tratamiento óptimo. El cultivo también se utiliza para enriquecer muestras diagnósticas con fines de investigación, como la secuenciación del genoma de MTB. Sin embargo, se desconoce si cultivar reduce la diversidad genética de la muestra diagnóstica, sesgando los resultados. Actualmente, las técnicas moleculares permiten evitar el cultivo en el diagnóstico, detectando resistencia a antibióticos más rápidamente, pero se limitan a identificar las mutaciones comunes asociadas a la resistencia a la rifampicina (RIF) e isoniazida (INH), los fármacos de primera línea. No obstante, la composición compleja de las muestras diagnósticas como el esputo sigue siendo un desafío para la secuenciación. Esta tesis presenta técnicas y estrategias de secuenciación para recuperar MTB a partir de esputos, centrándose en la diversidad genética en esputos y cultivos y explorando el potencial de la secuenciación para determinar resistencias. En el Capítulo 1 comparamos la diversidad genética entre pares de esputos y cultivos en dos entornos diferentes. Desarrollamos una técnica de secuenciación de esputos, realizando una secuenciación directa o enriquecida según la cantidad de MTB presente. Además, implementamos un flujo de análisis para descartar artefactos del procesamiento de muestras. Los resultados muestran una alta concordancia en la diversidad entre esputos y cultivos, cuestionando la hipótesis inicial del cuello de botella en el cultivo. En el Capítulo 2 exploramos las limitaciones del Gene Xpert MTB/RIF Ultra (XpertUltra) para identificar mutaciones de resistencia a RIF, examinando las mutaciones de resistencia más prevalentes en el sur de Mozambique. Utilizamos la secuenciación del genoma completo para identificar variantes de resistencia en cepas recolectadas en Manhiça, Mozambique. Detectamos dos cepas con mutaciones de resistencia a RIF no identificadas por el XpertUltra y una alta prevalencia de cepas resistentes a INH sin resistencia a RIF (no multirresistentes, MDR). Los resultados sugieren que el XpertUltra podría no detectar algunos casos de resistencia a RIF y/o INH, destacando la necesidad de incluir nuevas mutaciones en las pruebas moleculares. En el Capítulo 3 evaluamos el potencial de la secuenciación de amplicones para predecir la resistencia a antibióticos e identificar el linaje de las cepas. Diseñamos un panel de nueve genes asociados a la resistencia a siete antibióticos y dos regiones filogenéticas, poniendo a punto una PCR multiplex para amplificar todas las regiones en una sola reacción. A diferencia de otros paneles, los cebadores diseñados cubren los genes completos para detectar todas las mutaciones presentes. La secuenciación se realiza con MinION (Nanopore), una plataforma portátil con análisis en tiempo real. Comparamos las variantes obtenidas con las de Illumina para calibrar los parámetros del llamado de variantes y evitar falsos positivos. Los resultados muestran una alta correlación entre MinION e Illumina en la detección de resistencia e identificación de linajes, independientemente del tipo de muestra. Estos resultados, junto con el análisis en tiempo real de MinION, son prometedores para su implementación en atención primaria. En conclusión, esta tesis contribuye a los avances en la genómica de muestras diagnósticas. Por un lado, demostrando que el cultivo refleja la diversidad genética del esputo, y por otro, revelando el potencial de la secuenciación del genoma y de amplicones para predecir resistencia a antibióticos. Las técnicas y resultados que se presentan contribuirán a promover la secuenciación directa de esputo como técnica de diagnóstico rápida y precisa, pero también su uso para la investigación., [CA] La detecció i diagnòstic de resistències en Mycobacterium tuberculosis (MTB) suposa un repte per al control de la tuberculosi (TB). La tècnica de referència ha estat el cultiu de mostres diagnòstiques, però aquest procés és lent, retardant els resultats durant setmanes o mesos i dificultant la prescripció d'un tractament òptim. El cultiu també s'ha utilitzat per enriquir mostres diagnòstiques amb finalitats de recerca, com la seqüenciació del genoma de MTB. No obstant això, encara es desconeix si el cultiu redueix la diversitat genètica de la mostra diagnòstica, cosa que podria generar un biaix en els resultats. Actualment, les tècniques moleculars han permès evitar el cultiu en el diagnòstic, detectant resistència a antibiòtics més ràpidament, però es limiten a identificar les mutacions comunes associades a resistència a la rifampicina (RIF) i isoniazida (INH), els fàrmacs de primera línia. Tanmateix, la composició complexa de les mostres diagnòstiques com l'esput segueix sent un repte per a la seqüenciació. Aquesta tesi presenta tècniques i estratègies de seqüenciació per recuperar MTB a partir d'esputs, centrant-se en la diversitat genètica en esputs i cultius i explorant el potencial de la seqüenciació per determinar resistències. Al Capítol 1 comparem la diversitat genètica entre parelles d'esputs i cultius en dos entorns diferents. Desenvolupem una tècnica de seqüenciació d'esputs, realitzant una seqüenciació directa o enriquida segons la quantitat de MTB present. A més, implementem un flux d'anàlisi per descartar artefactes del processament de mostres. Els resultats mostren una alta concordança en la diversitat entre esputs i cultius, qüestionant la hipòtesi inicial d'un coll de botella al cultiu. Al Capítol 2 explorem les limitacions de la prova molecular Gene Xpert MTB/RIF Ultra (XpertUltra) per identificar mutacions de resistència a RIF, examinant les mutacions de resistència més prevalents al sud de Moçambic. Utilitzem la seqüenciació del genoma complet per identificar variants de resistència a antibiòtics en soques recol·lectades a Manhiça, Moçambic. Detectem dues soques amb mutacions de resistència a rifampicina no identificades per l'XpertUltra i una alta prevalença de soques resistents a INH sense resistència a RIF (no multiressistents, MDR). Els resultats sugereixen que l'XpertUltra pot no detectar alguns casos de resistència a RIF i/o INH, destacant la necessitat d'incloure noves mutacions en proves moleculars. Al Capítol 3 avaluem el potencial de la seqüenciació d'amplicons per predir resistència a antibiòtics i identificar el llinatge de les soques. Dissenyem un panell de nou gens associats a resistència a set antibiòtics i dues regions filogenètiques, posant a punt una PCR multiplex per amplificar totes les regions en una sola reacció. A diferència d'altres panells, els encebadors dissenyats cobreixen els gens complets, per detectar totes les mutacions presents. La seqüenciació es realitza amb MinION (Nanopore), una plataforma portàtil amb anàlisi en temps real. Comparem les variants obtingudes amb les d'Illumina per calibrar paràmetres per cridar de variants i evitar falsos positius. Els resultats mostren una alta correlació entre MinION i Illumina en la detecció de resistència i identificació de llinatges, independentment del tipus de mostra. Aquests resultats, juntament amb l'anàlisi en temps real de MinION, són prometedors per a la seva implementació en atenció primària. En conclusió, aquesta tesi contribueix als avanços en la genòmica directa de mostra diagnòstica. D'una banda, demostrant que el cultiu reflecteix la diversitat genètica de l'esput i, d'altra banda, revelant el potencial de la seqüenciació del genoma i d'amplicons per predir resistència a antibiòtics. Els resultats obtinguts superen les limitacions de les proves moleculars actuals, i les tècniques presentades podrien promoure la seqüenciació directa d'esput com a eina de diagnòstic ràpida i precisa, així com per a la investigació., [EN] Mycobacterium tuberculosis (MTB) detection and diagnosis of drug resistance(DR) have been a challenge for tuberculosis(TB) control. Culturing mycobacteria from diagnostic samples has been the most commonly used diagnostic technique. However, culturing depends on MTB's slow growth, delaying results and the prescription of optimal treatment for weeks to months. Culture is also essential for research purposes such as MTB genomics. However, it remains unclear whether it causes a bottleneck in the sample's original genetic diversity, potentially biasing results. Skipping the culturing step has been possible with the introduction of molecular techniques in surveillance systems. These reduce turnaround time and allow MTB and DR detection through a single assay. However, such tests are limited to detecting common mutations associated with rifampicin(RIF) and isoniazid(INH) resistance. Moreover, the complex composition of diagnostic samples, like sputum, continues to challenge sequencing workflows in research. In this thesis, we explore different sequencing approaches to recover and sequence MTB from sputum samples, focusing on overcoming the hypothesized culture bottleneck and evaluating the potential of sequencing for DR prediction. In Chapter 1, we compare genetic diversity within sputum-culture paired samples in two settings. We implement a culture-free sequencing (cfWGS) approach for sputum, using both direct and enriched sequencing, depending on the initial amount of MTB DNA. We also develop an analysis pipeline to filter artifactual variants from cfWGS approaches. To generalize results, three additional datasets are reanalyzed. The results show high concordance in genetic diversity between sputum-culture pairs, both in terms of presence and frequency of variants. These results contradict the initial culture bottleneck assumption, emphasizing the importance of tailored filtering steps depending on sample complexity. In Chapter 2, we explore the limitations of the Gene Xpert MTB/RIF Ultra (XpertUltra) for detecting non-common mutations and screen for prevalent DR mutations in southern Mozambique. We use WGS to identify DR variants in strains collected in Manhiça (Mozambique) during two time periods. Two strains were found to harbor RIF resistance mutations beyond XpertUltra's detection scope. We also detect a high prevalence of INH-resistant strains without RIF resistance (non-MDR TB). This suggests that XpertUltra, the primary diagnostic tool in the region, sometimes misclassifies RIF-resistant cases, highlighting the need for expanded drug and mutation coverage in molecular diagnostic tests. In Chapter 3, we assess the potential of targeted sequencing for DR prediction and lineage identification by designing a gene panel of 9 genes associated with resistance to 7 drugs and two phylogenetic regions. We develop a multiplex PCR to amplify all target regions in one reaction. Unlike other commercial panels, our primers cover entire genes allowing the identification of all mutations, not just those in hotspot regions. We employ the portable MinION (Nanopore) platform, which provides real-time analysis. A key aim is to calibrate parameters for MinION variant calling by comparing its results to Illumina sequencing, establishing a frequency cut-off to avoid false positives due to MinION's error rate. Our results show high concordance between MinION and Illumina in detecting DR and genotyping, regardless of the sample type. These findings present a significant advantage for future implementation in point-of-care systems. This thesis advances the field of cfWGS by confirming that culture mirrors sputum's genetic diversity and demonstrating the potential of whole genome and targeted sequencing to overcome the limitations of current molecular diagnostic tests in predicting DR. The techniques and findings presented could help promote cfWGS as a front-line approach for faster, more accurate diagnosis, and contribute to further research., This work has been supported by the following: European Research Council (ERC): H2020-ERC-COG/0800; Ministerio Español de Ciencia e Innovación: PID2022-137607OB-I00; Fundació La Caixa: HR21-00415, International Science and Technology Center (ISTC): Project #G-2143 and National Institute of Allergy and Infectious Diseases (NIH). This work was also supported by STOP TB partnership [STBP/TBREACH/GSA/W5-30: CA-3-D000920001], the TB Portals programme of the National Institutes of Health, the European Research Council [101001038-TB-RECONNECT: H2020-ERC-COG/0800 and 638553-TB-ACCELERATE], Generalitat Valenciana [AICO/2018/113], the Spanish Ministry of Science and Innovation [PID2019-104477RB-I00] and the Ministerio de Economía, Indústria y Competividad (SAF2016-77346-R)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

The SeqCOVID-Spain consortium: unravelling the dynamics of the COVID-19 first epidemic wave in Spain

  • Chiner-Oms, Álvaro
  • López, Mariana G.
  • García de Viedma, Darío
  • Ruiz-Rodríguez, Paula
  • Bracho, María Alma
  • Cancino-Muñoz, Irving
  • D’Auria, Giuseppe
  • Marco, Griselda de
  • García-González, Neris
  • Goig, Galo A.
  • Gómez-Navarro, Inmaculada
  • Jiménez-Serrano, Santiago
  • Martínez-Priego, Llucia
  • Ruiz-Hueso, Paula
  • Ruiz-Roldán, Lidia
  • Torres-Puente, Manuela
  • Coscollá, Mireia
  • González-Candelas, Fernando
  • Comas, Iñaki
  • Seqcovid-Spain Consortium
Póster presentado a la Applied Bioinformatics and Public Health Microbiology 2021 Virtual Conference, celebrada del 5 al 7 de mayo de 2021., The COVID-19 pandemic has shaken the world since the beginning of 2020. Spain is among the European countries with the highest incidence of the disease during the first pandemic wave. We established a multidisciplinary consortium to monitor and study the evolution of the epidemic, with the aim of contributing to decision making and stopping rapid spreading across the country. We present the results for 2170 sequences from the first wave of the SARS-Cov-2 epidemic in Spain, representing 12% of diagnosed cases until 14th March. This effort allows us to document at least 500 initialintroductions, between early February-March from multiple international sources. Importantly, we document the early raise of two dominant genetic variants in Spain (Spanish Epidemic Clades), named SEC7 and SEC8, likely amplified by superspreading events. In sharp contrast to other non Asian countries those two variants were closely related to the initial variants of SARS-CoV-2 described in Asia and represented 40% of the genome sequences analyzed. The two dominant SECs were widely spread across the country compared to other genetic variants with SEC8 reaching a 60% prevalence just before the lockdown. Employing Bayesian phylodynamic analysis, we inferred a reduction in the effective reproductive number of these two SECs from around 2.5 to below 0.5 after the implementation of strict public-health interventions in mid-March. The effects of lockdown on the genetic variants of the virus are reflected in the general replacement of pre-existing SECs by a new variant at the beginning of the summer season. Our results reveal a significant difference in the genetic makeup of the epidemic in Spain and support the effectiveness of lockdown measures in controlling virus spread even for the most successful genetic variants., This work was funded by the Instituto de Salud Carlos III project COV20/00140, Spanish National Research Council project CSIC-COV19-021, Ministerio de Ciencia PID2019-104477RB-I00 and ERC StG 638553 to IC, and BFU2017-89594R to FGC. MC is supported by Ramón y Cajal program from Ministerio de Ciencia and grants RTI2018-094399-A-I00 and SEJI/2019/011., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections

  • Moreno-Molina, Miguel
  • Shubladze, Natalia
  • Khurtsilava, Iza
  • Avaliani, Zaza
  • Bablishvili, Nino
  • Torres-Puente, Manuela
  • Villamayor, Luis
  • Gabrielian, Andrei
  • Rosenthal, Alex
  • Vilaplana, Cristina
  • Gagneux, Sebastien
  • Kempker, Russell R
  • Vashakidze, Sergo
  • Comas, Iñaki
11 páginas, 5 figuras, 1 tabla, Polyclonal infections occur when at least two unrelated strains of the same pathogen are detected in an individual. This has been linked to worse clinical outcomes in tuberculosis, as undetected strains with different antibiotic resistance profiles can lead to treatment failure. Here, we examine the amount of polyclonal infections in sputum and surgical resections from patients with tuberculosis in the country of Georgia. For this purpose, we sequence and analyse the genomes of Mycobacterium tuberculosis isolated from the samples, acquired through an observational clinical study (NCT02715271). Access to the lung enhanced the detection of multiple strains (40% of surgery cases) as opposed to just using a sputum sample (0-5% in the general population). We show that polyclonal infections often involve genetically distant strains and can be associated with reversion of the patient's drug susceptibility profile over time. In addition, we find different patterns of genetic diversity within lesions and across patients, including mutational signatures known to be associated with oxidative damage; this suggests that reactive oxygen species may be acting as a selective pressure in the granuloma environment. Our results support the idea that the magnitude of polyclonal infections in high-burden tuberculosis settings is underestimated when only testing sputum samples., The authors were supported by projects SAF2016-77346-R and PID2019-104477RB-I00 awarded to IC and the grant BES-2017-079656 awarded to MM by the Spanish Ministry of Economy and Competitiveness and Ministry of Science, the ERC project 638553-TBACCELERATE awarded to IC, Spanish Government-FEDER Funds through CV contract CPII18/00031 and grant PI16/01511, and Generalitat Valencia Grant to I.C. (code PROMETEO/2020/012). The grant providers played no part in study design, data collection, and analysis, or the preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Gene evolutionary trajectories in Mycobacterium tuberculosis reveal temporal signs of selection

  • Chiner-Oms, Álvaro
  • López, Mariana G.
  • Moreno-Molina, Miguel
  • Furió, Victoria
  • Comas, Iñaki
11 páginas, 4 figuras, 1 tabla y fórmulas. Plots of all trajectories calculated (Dataset S7) have been deposited in Figshare (https://dx.doi.org/10.6084/m9.figshare.19335854). Previously published data were also used for this work [data from Brites et al. (4), Coll et al. (29), Stucki et al. (30), Guerra-Assunc¸~ao et al. (31), Zignol et al. (32), Bos et al. (33), Ates et al. (34), Comas et al. (10, 35), Borrell et al. (36), and Cancino-Mu~noz et al. (37)]., SignificancePrevious attempts to identify the action of natural selection in the Mycobacterium tuberculosis complex (MTBC) were limited by sample size and averaging across time and lineages. We investigate changes in selective pressures across time for every single gene of the MTBC. We developed a methodology to analyze temporal signals of selection in a large dataset (∼5,000 complete genomes) and showed that 1) almost half of the genes seem to have been under positive selection at some point in time; 2) experimentally confirmed epitopes tend to accumulate more mutations in deeper branches than in external branches; and 3) temporal signals identify genes that were conserved in the past but under positive selection in the present, suggesting ongoing adaptation to the host., This project received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program Grant 101001038 (TB-RECONNECT). In addition, this work was funded by Ministerio de Ciencia (Spanish Government) Project PID2019- 104477RB-I00 and Generalitat Valenciana Project AICO/2018/113. This research work was also funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Deciphering the tangible spatio-temporal spread of a 25 years tuberculosis outbreak boosted by social determinants

  • López, Mariana G.
  • Campos-Herrero, M. Isolina
  • Torres-Puente, Manuela
  • Cañas, Fernando
  • Comín, Jessica
  • Copado, Rodolfo
  • Wintringer, Penelope
  • Iqbal, Zamin
  • Lagarejos, Eduardo
  • Moreno-Molina, Miguel
  • Pérez-Lago, Laura
  • Pino, Berta
  • Sante, Laura
  • García de Viedma, Darío
  • Samper, Sofía
  • Comas, Iñaki
Background. Outbreak strains are good candidates to look for intrinsic transmissibility as they are responsible for a large number of cases with sustained transmission. However, assessment of the success of long-lived outbreak strains has been flawed by the use of low-resolution typing methods and restricted geographical investigations. We now have the potential to address the nature of outbreak strains by combining large genomic datasets and phylodynamic approaches. Methods. We retrospectively sequenced the whole genome of representative samples assigned to an outbreak circulating in the Canary Islands (GC) since 1993; accounting for ~20% of local TB cases. We selected a panel of specific SNP markers to in-silico search for additional outbreak related sequences within publicly-available TB genomic data. Using this information we inferred the origin, spread and epidemiological parameters of the GC-outbreak. Findings. Our approach allowed us to accurately trace both the historical and recent dispersion of the strain. We evidenced its high success within the Canarian archipelago but found a limited expansion abroad. Estimation of epidemiological parameters from genomic data contradicts a distinct biology of the GC-strain. Interpretation. With the increasing availability of genomic data allowing for an accurate inference of strain spread and key epidemiological parameters, we can now revisit the link between Mycobacterium tuberculosis genotypes and transmission, as routinely done for SARS-CoV-2 variants of concern. We show that the success of the GC-strain is better explained by social determinants rather than intrinsically higher bacterial transmissibility. Our approach can be used to trace and characterize strains of interest worldwide., This study was founded by Instituto de Salud Carlos III (FIS18/0336), Gobierno de Aragon/Fondo Social Europeo Construyendo Europa desde Aragon to SS. European Research Council (101001038-TB-RECONNECT), the Ministerio de Economía, Industria y Competividad (PID2019-104477RB-I00) to IC., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

  • Antimycobacterial Susceptibility Testing Group
  • Georghiou, Sophia B.
  • Rodwell, Timothy C.
  • Korobitsyn, Alexei
  • Abbadi, Said H.
  • Ajbani, Kanchan
  • Alffenaar, Jan-Willem
  • Alland, David
  • Alvarez, Nataly
  • Andres, Sönke
  • Ardizzoni, Elisa
  • Aubry, Alexandra
  • Baldan, Rossella
  • Ballif, Marie
  • Barilar, Ivan
  • Böttger, Erik C.
  • Chakravorty, Soumitesh
  • Claxton, Pauline M.
  • Cirillo, Daniela M.
  • Comas, Iñaki
  • Coulter, Chris
  • Denkinger, Claudia M.
  • Derendinger, Brigitta
  • Desmond, Edward P.
  • Steenwinkel, Jurriaan E. M. de
  • Dheda, Keertan
  • Diacon, Andreas H.
  • Dolinger, David L.
  • Dooley, Kelly E.
  • Egger, Matthias
  • Ehsani, Soudeh
  • Farhat, Maha R.
  • Fattorini, Lanfranco
  • Finci, Iris
  • Fournier Le Ray, Laure
  • Furió, Victoria
  • Groenheit, Ramona
  • Gumbo, Tawanda
  • Heysell, Scott K.
  • Hillemann, Doris
  • Hoffmann, Harald
  • Hsueh, Po-Ren
  • Hu, Yi
  • Huang, Hairong
  • Hussain, Alamdar
  • Ismail, Farzana
  • Izumi, Kiyohiko
  • Jagielski, Tomasz
  • Johnson, John L.
  • Kambli, Priti
  • Kaniga, Koné
  • Karunaratne, G. H. R. Eranga
  • Sharma, Meenu Kaushal
  • Keller, Peter M.
  • Kelly, Ellis C.
  • Kholina, Margarita
  • Kohli, Mikashmi
  • Kranzer, Katharina
  • Laurenson, Ian F.
  • Limberis, Jason
  • Lin, S-Y. Grace
  • Liu, Yongge
  • López-Gavín, Alexandre
  • Lyander, Anna
  • Machado, Diana
  • Martínez Fernández, Elena
  • Masood, Faisal
  • Mitarai, Satoshi
  • Mvelase, Nomonde R.
  • Niemann, Stefan
  • Nikolayevskyy, Vladyslav
  • Maurer, Florian P.
  • Merker, Matthias
  • Miotto, Paolo
  • Omar, Shaheed V.
  • Otto-Knapp, Ralf
  • Palaci, Moisés
  • Palacios Gutiérrez, Juan José
  • Peacock, Sharon J.
  • Peloquin, Charles A.
  • Perera, Jennifer
  • Pierre-Audigier, Catherine
  • Pholwat, Suporn
  • Posey, James E.
  • Prammananan, Therdsak
  • Rigouts, Leen
  • Robledo, Jaime
  • Rockwood, Neesha
  • Rodrigues, Camilla
  • Salfinger, Max
  • Schechter, Marcos C.
  • Seifert, Marva
  • Sengstake, Sarah
  • Shinnick, Thomas
  • Shubladze, Natalia
  • Sintchenko, Vitali
  • Sirgel, Frederick
  • Somasundaram, Sulochana
  • Sterling, Timothy R.
  • Spitaleri, Andrea
  • Streicher, Elizabeth
  • Supply, Philip
  • Svensson, Erik
  • Tagliani, Elisa
  • Tahseen, Sabira
  • Takaki, Akiko
  • Theron, Grant
  • Torrea, Gabriela
  • Van Deun, Armand
  • van Ingen, Jakko
  • Van Rie, Annelies
  • van Soolingen, Dick
  • Vargas Jr, Roger
  • Venter, Amour
  • Veziris, Nicolas
  • Villellas, Cristina
  • Viveiros, Miguel
  • Warren, Robin
  • Wen, Shu'an
  • Werngren, Jim
  • Wilkinson, Robert J.
  • Yang, Caie
  • Yılmaz, F. Ferda
  • Zhang, Tingting
  • Zimenkov, Danila
  • Ismail, Nazir
  • Köser, Claudio U.
  • Schön, Thomas
11 páginas, 2 figuras, 1 tabla, Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance., I. Comas was supported by PID2019-104477RB-I00 from the Spanish Science Ministry and by ERC (CoG 101001038), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Fine-grain population structure and transmission patterns of Mycobacterium tuberculosis in southern Mozambique, a high TB/HIV burden area

  • Saavedra Cervera, Belén
  • López, Mariana G.
  • Chiner-Oms, Álvaro
  • García Marín, Ana María
  • Cancino-Muñoz, Irving
  • Torres-Puente, Manuela
  • Villamayor, Luis
  • Madrazo-Moya, Carlos Francisco
  • Mambuque, Edson
  • Sequera, Guillermo Víctor
  • Respeito, Durval
  • Blanco, Silvia
  • Augusto, Orvalho
  • López-Varela, Elisa
  • Garcia-Basteiro, Alberto L.
  • Comas, Iñaki
14 paginas, 5 figuras, 2 tablas., Genomic studies of the Mycobacterium tuberculosis complex (MTBC) might shed light on the dynamics of its transmission, especially in high-burden settings, where recent outbreaks are embedded in the complex natural history of the disease. To this end, we conducted a 1 year prospective surveillance-based study in Mozambique. We applied whole-genome sequencing (WGS) to 295 positive cultures. We fully characterized MTBC isolates by phylogenetics and dating evaluation, and carried out a molecular epidemiology analysis to investigate further associations with pre-defined transmission risk factors. The majority of strains (49.5%, 136/275) belonged to lineage (L) 4; 57.8 % of them (159/275) were in genomic transmission clusters (cut-off 5 SNPs), and a strikingly high proportion (45.5%) shared an identical genotype (0 SNP pairwise distance). We found two 'likely endemic' clades, comprising 67 strains, belonging to L1.2, which dated back to the late 19th century and were associated with recent spread among people living with human immunodeficiency virus (PLHIV). We describe for the first time the population structure of MTBC in our region, a high tuberculosis (TB)/HIV burden area. Clustering analysis revealed an unforeseen pattern of spread and high rates of progression to active TB, suggesting weaknesses in TB control activities. The long-term presence of local strains in Mozambique, which were responsible for large transmission among HIV/TB-coinfected patients, calls into question the role of HIV in TB transmission., This project received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programmes 101001038 (TB-RECONNECT), PID2019-104477RB-I00 from Ministerio de Economía y Competitividad (Spanish Government) (to I.C.). We acknowledge support from the Spanish Ministry of Science, Innovation and Universities through the ‘Centro de Excelencia Severo Ochoa 2019–2023’.Programme (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Programme. B.S receives a pre-doctoral fellowship from the Secretariat of Universities and Research, Ministry of Enterprise and Knowledge of the Government of Catalonia and co-funded by European Social Fund (AGAUR)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Epidemiological cluster identification using multiple data sources: an approach using logistic regression

  • Susvitasari, Kurnia
  • Tupper, Paul F.
  • Cancino-Muñoz, Irving
  • López, Mariana G.
  • Comas, Iñaki
  • Colijn, Caroline
In the management of infectious disease outbreaks, grouping cases into clusters and understanding their underlying epidemiology are fundamental tasks. In genomic epidemiology, clusters are typically identified either using pathogen sequences alone or with sequences in combination with epidemiological data such as location and time of collection. However, it may not be feasible to culture and sequence all pathogen isolates, so sequence data may not be available for all cases. This presents challenges for identifying clusters and understanding epidemiology, because these cases may be important for transmission. Demographic, clinical and location data are likely to be available for unsequenced cases, and comprise partial information about their clustering. Here, we use statistical modelling to assign unsequenced cases to clusters already identified by genomic methods, assuming that a more direct method of linking individuals, such as contact tracing, is not available. We build our model on pairwise similarity between cases to predict whether cases cluster together, in contrast to using individual case data to predict the cases' clusters. We then develop methods that allow us to determine whether a pair of unsequenced cases are likely to cluster together, to group them into their most probable clusters, to identify which are most likely to be members of a specific (known) cluster, and to estimate the true size of a known cluster given a set of unsequenced cases. We apply our method to tuberculosis data from Valencia, Spain. Among other applications, we find that clustering can be predicted successfully using spatial distance between cases and whether nationality is the same. We can identify the correct cluster for an unsequenced case, among 38 possible clusters, with an accuracy of approximately 35 %, higher than both direct multinomial regression (17 %) and random selection (< 5 %)., This project received funding from the Euroepan Research Council ERC TB-RECONNECT 101001038, Ministerio de Ciencia (Spanish Government) PID2019-104477RB-100 and by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Deciphering the Tangible Spatio-Temporal Spread of a 25-Year Tuberculosis Outbreak Boosted by Social Determinants

  • López, Mariana G.
  • Campos-Herrero, M. Isolina
  • Torres-Puente, Manuela
  • Canas, Fernando
  • Comin, Jessica
  • Copado, Rodolfo
  • Wintringer, Penelope
  • Iqbal, Zamin
  • Lagarejos, Eduardo
  • Moreno-Molina, Miguel
  • Pérez-Lago, Laura
  • Pino, Berta
  • Sante, Laura
  • García de Viedma, Darío
  • Samper, Sofia
  • Comas, Iñaki
15 páginas, 5 figuras, 1 tabla, Outbreak strains of Mycobacterium tuberculosis are promising candidates as targets in the search for intrinsic determinants of transmissibility, as they are responsible for many cases with sustained transmission; however, the use of low-resolution typing methods and restricted geographical investigations represent flaws in assessing the success of long-lived outbreak strains. We can now address the nature of outbreak strains by combining large genomic data sets and phylodynamic approaches. We retrospectively sequenced the whole genome of representative samples assigned to an outbreak circulating in the Canary Islands (the GC strain) since 1993, which accounts for ~20% of local tuberculosis cases. We selected a panel of specific single nucleotide polymorphism (SNP) markers for an in-silico search for additional outbreak-related sequences within publicly available tuberculosis genomic data. Using this information, we inferred the origin, spread, and epidemiological parameters of the GC strain. Our approach allowed us to accurately trace the historical and more recent dispersion of the GC strain. We provide evidence of a highly successful nature within the Canarian archipelago but limited expansion abroad. Estimation of epidemiological parameters from genomic data disagree with a distinctive biology of the GC strain. With the increasing availability of genomic data allowing for the accurate inference of strain spread and critical epidemiological parameters, we can now revisit the link between Mycobacterium tuberculosis genotypes and transmission, as is routinely carried out for SARS-CoV-2 variants of concern. We demonstrate that social determinants rather than intrinsically higher bacterial transmissibility better explain the success of the GC strain. Importantly, our approach can be used to trace and characterize strains of interest worldwide. IMPORTANCE Infectious disease outbreaks represent a significant problem for public health. Tracing outbreak expansion and understanding the main factors behind emergence and persistence remain critical to effective disease control. Our study allows researchers and public health authorities to use Whole-Genome Sequencing-based methods to trace outbreaks, and shows how available epidemiological information helps to evaluate the factors underpinning outbreak persistence. Taking advantage of all the freely available information placed in public repositories, researchers can accurately establish the expansion of an outbreak beyond original boundaries, and determine the potential risk of a strain to inform health authorities which, in turn, can define target strategies to mitigate expansion and persistence. Finally, we show the need to evaluate strain transmissibility in different geographic contexts to unequivocally associate spread to local or pathogenic factors, an important lesson taken from genomic surveillance of SARS-CoV-2., This project has been funded by the European Research Council (101001038-TBRECONNECT), the Ministerio de Economía, Industria y Competitividad (PID2019-104477RB-I00), and the European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global) to I.C. This project has been funded by the Instituto de Salud Carlos III (FIS18/0336) and the Gobierno de Aragón/Fondo Social Europeo “Construyendo Europa desde Aragón” to SS, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Tracking SARS-CoV-2 introductions in Mozambique using pandemic-scale phylogenies: a retrospective observational study

  • Martínez-Martínez, Francisco José
  • Massinga, Arsenia J
  • Jesus, Áuria De
  • Ernesto, Rita M.
  • Cano-Jiménez, Pablo
  • Chiner-Oms, Álvaro
  • Gómez-Navarro, Inmaculada
  • Guillot-Fernández, Marina
  • Guinovart, Caterina
  • Sitoe, Antonio
  • Vubil, Delfino
  • Bila, Rubao
  • Gujamo, Rufino
  • Enosse, Sonia
  • Jiménez-Serrano, Santiago
  • Torres-Puente, Manuela
  • Comas, Iñaki
  • Mandomando, Inacio
  • López, Mariana G.
  • Mayor, Alfredo
9 hojas, 4 figuras, 1 tabla. Demographic data of the participants are available in the appendix (pp 40–42). Genome sequences are publicly available on GISAID. All scripts used for the analysis, and beta and delta subtree files are publicly available at https://gitlab.com/tbgenomicsunit/mozcovid. The study protocol (appendix pp 1–35) and clinical questionnaire (appendix pp 36–39) will be available with publication, Background: From the start of the SARS-CoV-2 outbreak, global sequencing efforts have generated an unprecedented amount of genomic data. Nonetheless, unequal sampling between high-income and low-income countries hinders the implementation of genomic surveillance systems at the global and local level. Filling the knowledge gaps of genomic information and understanding pandemic dynamics in low-income countries is essential for public health decision making and to prepare for future pandemics. In this context, we aimed to discover the timing and origin of SARS-CoV-2 variant introductions in Mozambique, taking advantage of pandemic-scale phylogenies. Methods: We did a retrospective, observational study in southern Mozambique. Patients from Manhiça presenting with respiratory symptoms were recruited, and those enrolled in clinical trials were excluded. Data were included from three sources: (1) a prospective hospital-based surveillance study (MozCOVID), recruiting patients living in Manhiça, attending the Manhiça district hospital, and fulfilling the criteria of suspected COVID-19 case according to WHO; (2) symptomatic and asymptomatic individuals with SARS-CoV-2 infection recruited by the National Surveillance system; and (3) sequences from SARS-CoV-2-infected Mozambican cases deposited on the Global Initiative on Sharing Avian Influenza Data database. Positive samples amenable for sequencing were analysed. We used Ultrafast Sample placement on Existing tRees to understand the dynamics of beta and delta waves, using available genomic data. This tool can reconstruct a phylogeny with millions of sequences by efficient sample placement in a tree. We reconstructed a phylogeny (~7·6 million sequences) adding new and publicly available beta and delta sequences. Findings: A total of 5793 patients were recruited between Nov 1, 2020, and Aug 31, 2021. During this time, 133 328 COVID-19 cases were reported in Mozambique. 280 good quality new SARS-CoV-2 sequences were obtained after the inclusion criteria were applied and an additional 652 beta (B.1.351) and delta (B.1.617.2) public sequences were included from Mozambique. We evaluated 373 beta and 559 delta sequences. We identified 187 beta introductions (including 295 sequences), divided in 42 transmission groups and 145 unique introductions, mostly from South Africa, between August, 2020 and July, 2021. For delta, we identified 220 introductions (including 494 sequences), with 49 transmission groups and 171 unique introductions, mostly from the UK, India, and South Africa, between April and November, 2021. Interpretation: The timing and origin of introductions suggests that movement restrictions effectively avoided introductions from non-African countries, but not from surrounding countries. Our results raise questions about the imbalance between the consequences of restrictions and health benefits. This new understanding of pandemic dynamics in Mozambique can be used to inform public health interventions to control the spread of new variants. Funding: European and Developing Countries Clinical Trials, European Research Council, Bill & Melinda Gates Foundation, and Agència de Gestió d'Ajuts Universitaris i de Recerca., This publication was produced by MozCovid which is part of the EDCTP2 programme supported by the EU (grant number RIA2020EF-3005-MozCOVID). The COVID-19 testing was supported by Emory Global Health Institute, University of Emory, through the CHAMPS Program funded by the Bill & Melinda Gates Foundation (under the grant OPP1126780 to Robert Breiman, subcontract SC00003286). This work was also supported by the European Research Council under the EU’s Horizon 2020 Research and Innovation Program grant (101001038; TB-RECONNECT), the European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global), the Departament d’Universitats i Recerca de la Generalitat de Catalunya (AGAUR; 2021 SGR 01517), and the Ministerio de Ciencia e Innovación (Spanish Government) Project PID2019–104477RB-I00. CISM is supported by the Government of Mozambique and the Spanish Agency for International Development. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya (http://cerca.cat/en/suma/). We also acknowledge support from the Spanish Ministry of Science and Innovation and State Research Agency through the Centro de Excelencia Severo Ochoa 2019–2023 Program (CEX2018–000806-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Genomic approaches for tuberculosis management and control, Deploying sequencing advances to the clinic

  • Comas, Iñaki
  • López, Mariana G.
  • Chiner-Oms, Álvaro
  • Farhat, Maha R.
  • Semuto Ngabonziza, Jean Claude
  • Campos, Josefina
  • Moreno-Molina, Miguel
18 páginas, 2 figuras., Research at IC laboratory is funded by European Research Council (TB-RECONNECT Program Grant 101001038), Ministerio de Ciencia (Spanish Government) Project PID2019-104477RB-I00, European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global). JSN is funded by research project ‘Innovate to reduce rifampicin resistance tuberculosis in Rwanda and beyond’ with financial support from ITM’s SOFI programme supported by the Flemish Government, Science & Innovation. ACO is supported by a RyC grant RYC2021‐031461‐I funded by MCIN/AEI/ 10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

VIPERA: Viral Intra-Patient Evolution Reporting and Analysis

  • Álvarez-Herrera, Miguel
  • Sevilla, Jordi
  • Ruiz-Rodríguez, Paula
  • Vergara, Andrea
  • Vila, Jordi
  • Cano-Jiménez, Pablo
  • González-Candelas, Fernando
  • Comas, Iñaki
  • Coscollá, Mireia
Viral mutations within patients nurture the adaptive potential of SARS-CoV-2 during chronic infections, which are a potential source of variants of concern. However, there is no integrated framework for the evolutionary analysis of intra-patient SARS-CoV-2 serial samples. Herein we describe VIPERA (Viral Intra-Patient Evolution Reporting and Analysis), a new software that integrates the evaluation of the intra-patient ancestry of SARS-CoV-2 sequences with the analysis of evolutionary trajectories of serial sequences from the same viral infection. It has been validated using positive and negative control datasets and successfully applied to a novel case, contributing to easy and automatic analysis of intra-patient SARS-CoV-2 sequences., This work was funded by the Spanish Ministry of Science (CNS2022-135116) and the European Commission – NextGenerationEU (Regulation EU 2020/2094), through the Global Health Platform (PTI+ Salud Global) of the Spanish National Research Council (CSIC). MAH and PRR are supported by the PTI+ Salud Global. JS is supported by the CSIC’s JAE intro programme. FGC was funded by project PID2021-127010OB-I00 from the Spanish Ministry of Science and CIPROM2021-053 from the Generalitat Valenciana. IC is funded by the European Research Council (101001038-TB640 RECONNECT) and the Spanish Ministry of Economy, Industry and Competitiveness (PID2019- 104477RB-I00). MC is funded by the Spanish Ministry of Science (PID2021-123443OB-I00)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Detection of past and present selective pressures in the Mycobacterium tuberculosis complex genome

  • Chiner-Oms, Álvaro
  • López, Mariana G.
  • Comas, Iñaki
Póster presentado al: MEEHUBS2024 - Microbial Ecology and Evolution Hubs. Lausanne, Suiza, 9 al 11 de enero de 2024, The Mycobacterium tuberculosis complex (MTBC) is the causative agent of tuberculosis in humans and animals. It has no detectable recombination or horizontal gene transfer and displays a clonal population structure divided in 9 genetic lineages. Treatment of tuberculosis in humans generally involves a combination of 4 different antibiotics, and drug-resistant cases are currently a major concern for the World Health Organization. By applying novel bioinformatic approaches, we have studied the selective pressures that different parts of the genome have undergone throughout its evolutionary history. This has allowed us to identify key players in the MTBC evolution such as the phoR gene, which is associated with host-pathogen interactions and appears to be involved in transmission. In addition, we have identified mutations in specific genes that are linked to drug-resistance phenotypes, by assessing the pN/pS (or dN/dS) ratio across thousands of genomes on a genome-wide scale. Beyond mutations on coding regions, we have observed that selective pressures also fix mutations that either create new transcription start-sites or disrupt existing ones, a phenomenon that impacts the expression of downstream genes. Overall, our results show that evolutionary approaches are a valuable method for studying genomic determinants in bacterial pathogens, that have biomedical relevance, such as genetic determinants of virulence, transmission and drug resistance., This project received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program Grant 101001038 (TB-RECONNECT), Ministerio de Ciencia (Spanish Government) Project PID2019-104477RB-I00 to IC. This research work was also funded by the European Commission–NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global). ACO is supported by a RyC grant RYC2021‐031461‐I funded by MCIN/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR”.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Monitoring of first-line drug resistance mutations outside the scope of Xpert MTB/RIF Ultra is needed for successful control of DR-TB in Southern Mozambique

  • Mariner-Llicer, Carla
  • Saavedra Cervera, Belén
  • Mambuque, Edson
  • Gomes, Neide
  • Munguambe, Shilzia
  • Villamayor, Luis M.
  • Cancino-Muñoz, Irving
  • Torres-Puente, Manuela
  • Nguenha, Dinis
  • Respeito, Durval
  • Tembe, Gustavo
  • López, Mariana G.
  • Comas, Iñaki
  • García-Basteiro, Alberto L.
Multidrug-resistant(MDR) tuberculosis in Southern Africa is of great concern, exacerbated by the spread of a clone harboring a mutation missed by Xpert Ultra. In Southern Mozambique, the presence of such mutation and rising cases of non-MDR isoniazid resistance highlights the need to ensure accurate detection of antimicrobial-resistance in the country., This work was supported by STOP TB partnership (STBP/TBREACH/GSA/W5-30: CA-3-D000920001 to AGB), the TB Portals program of the National Institutes of Health, the European Research Council (TB RECONNECT: H2020-ERC-COG/0800 to I. C.,), Generalitat Valenciana (AICO/2018/113 to I. C.) and the Spanish Ministry of Science and Innovation (PID2019-104477RB-I00 to I. C.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

VIPERA: Viral Intra-Patient Evolution Reporting and Analysis

  • Álvarez-Herrera, Miguel
  • Sevilla, Jordi
  • Ruiz-Rodríguez, Paula
  • Vergara, Andrea
  • Vila, Jordi
  • Cano-Jiménez, Pablo
  • González-Candelas, Fernando
  • Comas, Iñaki
  • Coscollá, Mireia
15 páginas, 9 figuras, Viral mutations within patients nurture the adaptive potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during chronic infections, which are a potential source of variants of concern. However, there is no integrated framework for the evolutionary analysis of intra-patient SARS-CoV-2 serial samples. Herein, we describe Viral Intra-Patient Evolution Reporting and Analysis (VIPERA), a new software that integrates the evaluation of the intra-patient ancestry of SARS-CoV-2 sequences with the analysis of evolutionary trajectories of serial sequences from the same viral infection. We have validated it using positive and negative control datasets and have successfully applied it to a new case, which revealed population dynamics and evidence of adaptive evolution. VIPERA is available under a free software license at https://github.com/PathoGenOmics-Lab/VIPERA., This work is a part of project CNS2022-135116 funded by MCIN/AEI/10.13039/501100011033, by the European Union Next GenerationEU/PRTR, and grant PID2021-123443OB-I00 funded by MICIN/AEI/10.13039/501100011033 and ERDF A way of making Europe. M.A.H. and P.R.R. are supported by the PTI+ Salud Global European Commission – NextGenerationEU (Regulation EU 2020/2094). J.S. is supported by the CSIC’s JAE intro program. F.G.C. was funded by project PID2021-127010OB-I00 from the Spanish Ministry of Science and CIPROM2021-053 from the Generalitat Valenciana. I.C. is funded by the European Research Council (101001038-TB-RECONNECT) and the Spanish Ministry of Economy, Industry and Competitiveness (PID2019-104477RB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Role of the first WHO mutation catalogue in the diagnosis of antibiotic resistance in Mycobacterium tuberculosis in the Valencia Region, Spain: a retrospective genomic analysis

  • García Marín, Ana María
  • Cancino-Muñoz, Irving
  • Torres-Puente, Manuela
  • Villamayor, Luis M.
  • Borrás, Rafael
  • Borrás-Máñez, María
  • Bosque, Montserrat
  • Camarena, Juan J.
  • Colomer-Roig, Ester
  • Colomina, Javier
  • Escribano, Isabel
  • Esparcia-Rodríguez, Oscar
  • Gil-Brusola, Ana
  • Gimeno-Cardona, Concepción
  • Gimeno-Gascón, Adelina
  • Gomila-Sard, Bárbara
  • González-Granda, Damiana
  • Gonzalo-Jiménez, Nieves
  • Guna-Serrano, María del Remedio
  • López-Hontangas, José Luis
  • Martín-González, Coral
  • Moreno-Muñoz, Rosario
  • Navarro, David
  • Navarro, María
  • Orta, Nieves
  • Pérez, Elvira
  • Prat, Josep
  • Rodríguez, Juan Carlos
  • Ruiz-García, María Montserrat
  • Vanaclocha, Hermelinda
  • González-Candelas, Fernando
  • Furió, Victoria
  • Valencia Region Tuberculosis Working Group
  • Comas, Iñaki
9 páginas, 2 figuras, 1 tabla, Background: In June, 2021, WHO published the most complete catalogue to date of resistance-conferring mutations in Mycobacterium tuberculosis. Here, we aimed to assess the performance of genome-based antimicrobial resistance prediction using the catalogue and its potential for improving diagnostics in a real low-burden setting. Methods: In this retrospective population-based genomic study M tuberculosis isolates were collected from 25 clinical laboratories in the low-burden setting of the Valencia Region, Spain. Culture-positive tuberculosis cases reported by regional public health authorities between Jan 1, 2014, and Dec 31, 2016, were included. The drug resistance profiles of these isolates were predicted by the genomic identification, via whole-genome sequencing (WGS), of the high-confidence resistance-causing variants included in the catalogue and compared with the phenotype. We determined the minimum inhibitory concentration (MIC) of the isolates with discordant resistance profiles using the resazurin microtitre assay. Findings: WGS was performed on 785 M tuberculosis complex culture-positive isolates, and the WGS resistance prediction sensitivities were: 85·4% (95% CI 70·8–94·4) for isoniazid, 73·3% (44·9–92·2) for rifampicin, 50·0% (21·1–78·9) for ethambutol, and 57·1% (34·0–78·2) for pyrazinamide; all specificities were more than 99·6%. Sensitivity values were lower than previously reported, but the overall pan-susceptibility accuracy was 96·4%. Genotypic analysis revealed that four phenotypically susceptible isolates carried mutations (rpoB Leu430Pro and rpoB Ile491Phe for rifampicin and fabG1 Leu203Leu for isoniazid) known to give borderline resistance in standard phenotypic tests. Additionally, we identified three putative resistance-associated mutations (inhA Ser94Ala, katG Leu48Pro, and katG Gly273Arg for isoniazid) in samples with substantially higher MICs than those of susceptible isolates. Combining both genomic and phenotypic data, in accordance with the WHO diagnostic guidelines, we could detect two new multidrug-resistant cases. Additionally, we detected 11 (1·6%) of 706 isolates to be monoresistant to fluoroquinolone, which had been previously undetected. Interpretation: We showed that the WHO catalogue enables the detection of resistant cases missed in phenotypic testing in a low-burden region, thus allowing for better patient-tailored treatment. We also identified mutations not included in the catalogue, relevant at the local level. Evidence from this study, together with future updates of the catalogue, will probably lead in the future to the partial replacement of culture testing with WGS-based drug susceptibility testing in our setting. Funding: European Research Council and the Spanish Ministerio de Ciencia., This project received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program Grant 101001038 (TB-RECONNECT; awarded to IC), from Ministerio de Ciencia (Spanish Government) Project PID2019-104477RB-I00 (awarded to IC), and from Generalitat Valenciana Project AICO/2018/113 (awarded to IC). AMG-M is funded by a Formación deProfesorado Universitario grant programme (FPU19/04562) from Ministerio de Universidades (Spanish Government). IC is also supported by the European Commission–NextGenerationEU, through Centro Superior de Investigaciones Científicas Global Health Platform (PTI Salud Global). We thank all the members of the Valencia Region Tuberculosis Working Group., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections

  • Moreno-Molina, Miguel|||0000-0003-0305-4445
  • Shubladze, Natalia|||0000-0003-0580-9629
  • Khurtsilava, Iza
  • Avaliani, Zaza
  • Bablishvili, Nino
  • Torres-Puente, Manuela|||0000-0002-8352-180X
  • Villamayor, Luis
  • Gabrielian, Andrei
  • Rosenthal, Alex|||0000-0003-4190-9045
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
  • Gagneux, Sebastien|||0000-0001-7783-9048
  • Kempker, Russell R.
  • Vashakidze, Sergo
  • Comas, I.|||0000-0001-5504-9408
Polyclonal infections occur when at least two unrelated strains of the same pathogen are detected in an individual. This has been linked to worse clinical outcomes in tuberculosis, as undetected strains with different antibiotic resistance profiles can lead to treatment failure. Here, we examine the amount of polyclonal infections in sputum and surgical resections from patients with tuberculosis in the country of Georgia. For this purpose, we sequence and analyse the genomes of Mycobacterium tuberculosis isolated from the samples, acquired through an observational clinical study (NCT02715271). Access to the lung enhanced the detection of multiple strains (40% of surgery cases) as opposed to just using a sputum sample (0-5% in the general population). We show that polyclonal infections often involve genetically distant strains and can be associated with reversion of the patient's drug susceptibility profile over time. In addition, we find different patterns of genetic diversity within lesions and across patients, including mutational signatures known to be associated with oxidative damage; this suggests that reactive oxygen species may be acting as a selective pressure in the granuloma environment. Our results support the idea that the magnitude of polyclonal infections in high-burden tuberculosis settings is underestimated when only testing sputum samples. Polyclonal infections occur when at least two unrelated strains of the same pathogen are detected in an individual. Here, Moreno-Molina et al. analyse sputum and surgical resections from tuberculosis patients, showing that the magnitude of polyclonal infections can be underestimated when only testing sputum samples.